Juan Del Coso1, Juan José Salinero2, Beatriz Lara2, César Gallo-Salazar2, Francisco Areces2, Carlos Puente2, David Herrero2. 1. Exercise Physiology Laboratory, Camilo José Cela University, C/Castillo de Alarcon, 49, Villafranca del Castillo, 28692, Madrid, Spain. jdelcoso@ucjc.edu. 2. Exercise Physiology Laboratory, Camilo José Cela University, C/Castillo de Alarcon, 49, Villafranca del Castillo, 28692, Madrid, Spain.
Abstract
PURPOSE: Alpha-actinin-3, encoded by the ACTN3 gene, is an actin-binding protein with an important role in myofibril contraction and muscle force output. In humans, there is a relatively common deficiency of the α-actinin-3 due to homozygosity in a polymorphism of the ACTN3 gene (R577X, rs1815739), that has been related to decreased resistance to strain during voluntary muscle contractions. The purpose of this study was to investigate the influence of the ACTN3 genotype on the level of exercise-induced muscle damage attained by 23 experienced triathletes during an official half-ironman competition. METHODS: Before and after the race, a sample of venous blood was obtained and jump height was measured during a countermovement jump. The changes in serum creatine kinase (CK-MM isoform) were measured in the blood samples and muscle pain was measured with a visual analogue scale (0-10 cm). Data from RX heterozygotes and XX mutant homozygotes were grouped as X-allele carriers (n = 13) and compared to RR homozygotes (n = 10). RESULTS: Race time was very similar between groups (313 ± 31 vs. 313 ± 25 min; P = 0.45); however, pre-to-post-competition reduction in jump height was greater in X-allele carriers than RR homozygotes (-18.4 ± 11.4 vs. -8.2 ± 6.9%; P = 0.04). At the end of the race, X-allele carriers presented higher serum CK-MM concentrations (682 ± 144 vs. 472 ± 269 U/L; P = 0.03), and there was also a tendency for higher self-reported values of lower limb muscle pain (7.7 ± 1.1 vs. 6.3 ± 2.3 cm; P = 0.06). CONCLUSIONS: X-allele triathletes in the ACTN3 R577X polymorphism presented greater signs of exercise-induced muscle damage during a half-ironman race than RR homozygotes.
PURPOSE:Alpha-actinin-3, encoded by the ACTN3 gene, is an actin-binding protein with an important role in myofibril contraction and muscle force output. In humans, there is a relatively common deficiency of the α-actinin-3 due to homozygosity in a polymorphism of the ACTN3 gene (R577X, rs1815739), that has been related to decreased resistance to strain during voluntary muscle contractions. The purpose of this study was to investigate the influence of the ACTN3 genotype on the level of exercise-induced muscle damage attained by 23 experienced triathletes during an official half-ironman competition. METHODS: Before and after the race, a sample of venous blood was obtained and jump height was measured during a countermovement jump. The changes in serum creatine kinase (CK-MM isoform) were measured in the blood samples and muscle pain was measured with a visual analogue scale (0-10 cm). Data from RX heterozygotes and XX mutant homozygotes were grouped as X-allele carriers (n = 13) and compared to RR homozygotes (n = 10). RESULTS: Race time was very similar between groups (313 ± 31 vs. 313 ± 25 min; P = 0.45); however, pre-to-post-competition reduction in jump height was greater in X-allele carriers than RR homozygotes (-18.4 ± 11.4 vs. -8.2 ± 6.9%; P = 0.04). At the end of the race, X-allele carriers presented higher serum CK-MM concentrations (682 ± 144 vs. 472 ± 269 U/L; P = 0.03), and there was also a tendency for higher self-reported values of lower limb muscle pain (7.7 ± 1.1 vs. 6.3 ± 2.3 cm; P = 0.06). CONCLUSIONS: X-allele triathletes in the ACTN3R577X polymorphism presented greater signs of exercise-induced muscle damage during a half-ironman race than RR homozygotes.
Entities:
Keywords:
Endurance performance; Muscle fatigue; Rhabdomyolysis; Single nucleotide polymorphism; Triathlon
Authors: Juan Del Coso; Cristina González; Javier Abian-Vicen; Juan José Salinero Martín; Lidon Soriano; Francisco Areces; Diana Ruiz; Cesar Gallo; Beatriz Lara; Julio Calleja-González Journal: J Sports Sci Date: 2014-05-13 Impact factor: 3.337
Authors: Juan Del Coso; Francisco Areces; Juan José Salinero; Cristina González-Millán; Javier Abián-Vicén; Lidon Soriano; Diana Ruiz; César Gallo; Beatriz Lara; Julio Calleja-Gonzalez Journal: Eur J Appl Physiol Date: 2013-12-13 Impact factor: 3.078
Authors: Nir Eynon; Erik D Hanson; Alejandro Lucia; Peter J Houweling; Fleur Garton; Kathryn N North; David J Bishop Journal: Sports Med Date: 2013-09 Impact factor: 11.136
Authors: Juan Del Coso; Marjorie Valero; Juan José Salinero; Beatriz Lara; Germán Díaz; César Gallo-Salazar; Diana Ruiz-Vicente; Francisco Areces; Carlos Puente; Juan Carlos Carril; Ramón Cacabelos Journal: Eur J Appl Physiol Date: 2017-02-02 Impact factor: 3.078
Authors: Juan Del Coso; Danielle Hiam; Peter Houweling; Laura M Pérez; Nir Eynon; Alejandro Lucía Journal: Eur J Appl Physiol Date: 2018-10-16 Impact factor: 3.078
Authors: Juan Del Coso; Marjorie Valero; Juan José Salinero; Beatriz Lara; César Gallo-Salazar; Francisco Areces Journal: PLoS One Date: 2017-03-03 Impact factor: 3.240
Authors: Juan Del Coso; Gil Rodas; Miguel Ángel Buil; Javier Sánchez-Sánchez; Pedro López; Joaquín González-Ródenas; Pablo Gasulla-Anglés; Álvaro López-Samanes; Sergio Hernández-Sánchez; Ane Iztueta; Víctor Moreno-Pérez Journal: Genes (Basel) Date: 2022-09-12 Impact factor: 4.141